ZEV Biotech
Main Vertical
BioTech, HealthTech, NanoTech
Website
CEO/FOUNDER
Name and Surname
Maximiliano Irisarri
Linkedin Profile or Bio
Number of people on the Staff
8
Legal Form
Simplified Joint Stock Company (SAS)
Year of Founding
2018
Type of Company
ScaleUp
Development Stage
Traction
Province
Buenos Aires
City
San Martín
Main Business Model
B2B
Problem
Diagnosis based on molecular biology surpasses traditional clinical diagnosis in its ability to accurately diagnose hereditary and infectious diseases and pharmacogenomics, making it an essential cornerstone of Personalized Medicine. But only 10% of people around the world have full access to molecular biology tests.
Solutions Offered - Summary
By integrating proprietary reagents, hardware, and software into a single solution, IRIS empowers any hospital (our clients) to offer molecular diagnostics to patients. With its unique blend of cutting-edge technology, versatility, flexibility, scalabilit
Solutions Offered - Details
Zev Biotech developed a unique molecular diagnostics technology named IRIS for Personalized Medicine that any lab in the world can afford
Technologies Used
Artificial Intelligence, Automation, Bioinformatics - Artificial Intelligence, Robotics, Other
Counterparties of Interest abroad
Accelerator, Distributor, End Customer, Financing, Joint Venture, Local Partner, Validation
Industries served
Biochemistry, Biotechnology, HealthTech, Hospitals, Laboratories, Pharmaceutical
International Presence
BRAZIL
Investment Round:
Seed
Certifications
IIRIS® and two diagnostic kits have been approved by ANMAT — the Argentine regulatory agency, equivalent to the FDA in EEUU
Awards/Recognitions
Zev Biotech won an international competition from IDB-Lab, the innovation and venture capital arm of the Inter-American Development Bank
Presentation
E-mail
mirisarri@zevbiotech.com